Perlmutter Cancer Center

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Resected High Risk Malignant Salivary Gland Tumors
• Age: Between 18 - 100 Years
• Gender: Male or Female

• Other Inclusion Criteria:
  

  Pathologically proven diagnosis of a malignant major salivary gland tumor or malignant minor salivary gland tumor of the head and neck of the following histologic subtypes: 1) Intermediate-grade adenocarcinoma or intermediate-grade mucoepidermoid carcinoma. 2) High-grade adenocarcinoma or high-grade mucoepidermoid carcinoma or salivary duct carcinoma. 3)High-grade acinic cell carcinoma or high-grade (>30% solid component) adenoid cystic carcinoma.
  

You may not be eligible for this study if the following are true:

• 1) Patients with residual macroscopic disease after surgery; 2) Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years (for example, carcinoma in situ of the breast, oral cavity, or cervix are all permissible); 3) Prior systemic chemotherapy or radiation therapy for salivary gland malignancy; note that prior chemotherapy for a different cancer is allowable; 4) Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields;